Clinical Pharmacology and Biopharmaceutics are two interconnected fields that play crucial roles in understanding drug actions and optimizing drug therapy. Clinical pharmacology focuses on the study of how drugs interact with the human body, encompassing aspects such as pharmacokinetics, pharmacodynamics, and pharmacogenomics. It examines how drugs are absorbed, distributed, metabolized, and eliminated within the body, considering factors such as age, genetics, and disease states that may influence drug responses. Biopharmaceutics, on the other hand, delves into the scientific principles underlying drug delivery and formulation, aiming to optimize drug bioavailability and therapeutic efficacy. It investigates the physicochemical properties of drugs and their formulations, as well as the mechanisms governing drug release and absorption. The integration of clinical pharmacology and biopharmaceutics is essential for designing effective drug therapies. Biopharmaceutical factors such as drug solubility, permeability, and formulation influence drug absorption and bioavailability, which in turn impact drug concentrations at the site of action and subsequent pharmacological responses. Understanding these factors allows clinicians to optimize drug dosing regimens and select appropriate formulations to achieve desired therapeutic outcomes. Moreover, clinical pharmacology principles guide the interpretation of drug concentration data and help predict individual patient responses to treatment based on factors such as metabolism and drug interactions.
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States
Title : Advancement in dual lateral flow immunoassay design for sensitive, rapid detection of rotavirus and adenovirus in stool samples
Ayan Ahmed Isse, Genexus Biotech Company, Somalia
Title :
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Diversity analyses of microbial communities in Armanis gold-polymetallic mine and acid mine drainage: Bioremediation
Anna Khachatryan, SPC Armbiotechnology of NAS of Armenia, Armenia